RobertFMangesMD

PubMed

• 4 citations
  Safety and efficacy of durvalumab with R-CHOP or R2-CHOP in untreated, high-risk DLBCL: a phase 2, open-label trial
  Grzegorz S. Nowakowski, Wolfgang Willenbacher, Richard Greil, Thomas Stauffer Larsen, Krish Patel, Ulrich Jäger, Robert Manges, Lorenz Trümper, Hele Everaus, Nagesh Ka...> ;International Journal of Hematology. 2021 Nov 19
• 12 citations
  A phase 2 safety study of accelerated elotuzumab infusion, over less than 1 h, in combination with lenalidomide and dexamethasone, in patients with multiple myeloma.
  James R. Berenson, Robert F. Manges, Suprith Badarinath, Alan Cartmell, Kristi McIntyre, Roger M. Lyons, Wael A. Harb, Hesham Mohamed, Ali Nourbakhsh, Robert M. Rifkin> ;American Journal of Hematology. 2017 May 1
• 180 citations
  Randomized, Double-Blind, Phase II Study of Ruxolitinib or Placebo in Combination With Capecitabine in Patients With Metastatic Pancreatic Cancer for Whom Therapy With...
  Herbert Hurwitz, Nikhil Uppal, Stephanie Ann Wagner, Johanna C. Bendell, J. Thaddeus Beck, Seaborn M. Wade, John Nemunaitis, Philip J. Stella, J. Marc Pipas, Zev A. Wa...> ;Journal of Clinical Oncology. 2015 Sep 8
• 122 citations
  A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma.
  Peter M. Voorhees, Robert F. Manges, Pieter Sonneveld, Sundar Jagannath, George Somlo, Amrita Krishnan, Suzanne Lentzsch, Richard C. Frank, Sonja Zweegman, Pierre W. W...> ;British Journal of Haematology. 2013 May 1
• Apricot-P: A randomized placebo-controlled phase II study of COX-2 inhibitor apricoxib or placebo in combination with gemcitabine and erlotinib in advanced or metastat...
  Modiano M, Keogh GP, Manges R, Stella PJ, Milne G, Looper E, Zaknoen SL> ;J. Clin. Oncol.. 2012-02-01
• A phase II multicenter study of CNTO 328, an anti-IL-6 monoclonal antibody, in patients (pts) with relapsed or refractory multiple myeloma (MM).
  Voorhees PM, Manges RF, Somlo G, Lentzsch S, Jagannath S, Sonneveld P, Frank RC, Zweegman S, Wijermans PW, Thomas S> ;J. Clin. Oncol.. 2009-05-20
• Phase II study evaluating the efficacy and safety of CNTO328 in combination with dexamethasone for patients with relapsed/refractory multiple myeloma (MM).
  Voorhees PM, Manges RF, Sonneveld P, Somlo G, Jagannath S, Zweegman S, Munteanu M, Vermeulen JT, Xie H, Orlowski RZ> ;J. Clin. Oncol.. 2008-05-20
• Join now to see all